Literature DB >> 218554

Responsiveness to glucagon by isolated rat hepatocytes controlled by the redox state of the cytosolic nicotinamide--adenine dinucleotide couple acting on adenosine 3':5'-cyclic monophosphate phosphodiesterase.

M G Clark, I G Jarrett.   

Abstract

1. The effects of changes in the cytoplasmic [NADH]/[NAD+] ratio on the efficacy of glucagon to alter rates of metabolism in isolated rat hepatocytes were examined. 2. Under reduced conditions (with 10mM-lactate), 10nM-glucagon stimulated both gluconeogenesis and urea synthesis in isolated hepatocytes from 48h-starved rats; under oxidized conditions (with 10mM-pyruvate), 10nM-glucagon had no effect on either of these rates. 3. The ability of glucagon to alter the concentration of 3':5'-cyclic AMP and the rates of glucose output, glycogen breakdown and glycolysis in cells from fed rats were each affected by a change in the extracellular [lactate]/[pyruvate] ratio; minimal effects of glucagon occurred at low [lactate]/[pyruvate] ratios. 4. Dose-response curves for glucagon-mediated changes in cyclic AMP concentration and glucose output indicated that under oxidized conditions the ability of glucagon to alter each parameter was decreased without affecting the concentration of hormone at which half-maximal effects occurred. 5. The phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (0.05 mM) significantly reversed the inhibitory effects of pyruvate on glucagon-stimulated glucose output. 6. For exogenously added cyclic [3H]AMP(0.1 mM), oxidized conditions decreased the stimulatory effect on glucose output as well as the intracellular concentration of cyclic AMP attained, but did not alter the amount of cyclic [3H]AMP taken up. 7. The effects of lactate, pyruvate, NAD+ and NADH on cyclic AMP phosphodiesterase activities of rat hepatocytes were examined. 8. NADH (0.01--1 MM) inhibited the low-Km enzyme, particularly that which was associated with the plasma membrane. 9. The inhibition of membrane-bound cyclic AMP phosphodiesterase by NADH was specific, reversible and resulted in a decrease in the maximal velocity of the enzyme. 10. It is proposed that regulation of the membrane-bound low-Km cyclic AMP phosphodiesterase by nicotinamide nucleotides provides the molecular basis for the effect of redox state on the hormonal control of hepatocyte metabolism by glucagon.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 218554      PMCID: PMC1186304          DOI: 10.1042/bj1760805

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  39 in total

1.  A rapid and precise method for the determination of urea.

Authors:  J K FAWCETT; J E SCOTT
Journal:  J Clin Pathol       Date:  1960-03       Impact factor: 3.411

2.  Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue.

Authors:  C DE DUVE; B C PRESSMAN; R GIANETTO; R WATTIAUX; F APPELMANS
Journal:  Biochem J       Date:  1955-08       Impact factor: 3.857

3.  Effect of ethanol and lactate on the basal and glucagon-activated cyclic AMP formation in isolated hepatocytes.

Authors:  R Zederman; H Löw; K Hall
Journal:  FEBS Lett       Date:  1977-03-15       Impact factor: 4.124

4.  Thyroid hormone control of cyclic nucleotide phosphodiesterases and the regulation of the sensitivity of the liver to hormones.

Authors:  K A Gumaa; J S Hothersall; A L Greenbaum; P McLean
Journal:  FEBS Lett       Date:  1977-08-01       Impact factor: 4.124

5.  Solubilization and characterization of hormone- responsive phosphodiesterase activity of rat fat cells.

Authors:  C J Lovell-Smith; V C Manganiello; M Vaughan
Journal:  Biochim Biophys Acta       Date:  1977-04-27

6.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

7.  Insulin-sensitive adenosine 3',5'-cyclic monophosphate phosphodiesterase of hepatocyte plasma membrane.

Authors:  E Tria; S Scapin; C Cocco; P Luly
Journal:  Biochim Biophys Acta       Date:  1977-01-24

8.  Stimulation of a low Km phosphodiesterase from liver by insulin and glucagon.

Authors:  E G Loten; F D Assimacopoulos-Jeannet; J H Exton; C R Park
Journal:  J Biol Chem       Date:  1978-02-10       Impact factor: 5.157

9.  Effect of glucagon on metabolite compartmentation in isolated rat liver cells during gluconeogenesis from lactate.

Authors:  E A Siess; D G Brocks; H K Lattke; O H Wieland
Journal:  Biochem J       Date:  1977-08-15       Impact factor: 3.857

10.  Activities and some properties of adenylate cyclase and phosphodiesterase in muscle, liver and nervous tissues from vertebrates and invertebrates in relation to the control of the concentration of adenosine 3':5'-cyclic monophosphate.

Authors:  J R Arch; E A Newsholme
Journal:  Biochem J       Date:  1976-09-15       Impact factor: 3.857

View more
  5 in total

1.  Inhibition of hepatic gluconeogenesis by the Rp-diastereomer of adenosine cyclic 3',5'-phosphorothioate.

Authors:  C J Dragland-Meserve; M C Olivieri; L H Botelho
Journal:  Biochem J       Date:  1986-07-15       Impact factor: 3.857

2.  Stimulation of calcium efflux from rat liver mitochondria by adenosine 3'5 cyclic monophosphate.

Authors:  J H Arshad; E S Holdsworth
Journal:  J Membr Biol       Date:  1980-12-30       Impact factor: 1.843

3.  Mechanism of butyrate-induced vasorelaxation of rat mesenteric resistance artery.

Authors:  P I Aaronson; W McKinnon; L Poston
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

Review 4.  Glucagon, cyclic AMP, and hepatic glucose mobilization: A half-century of uncertainty.

Authors:  Robert L Rodgers
Journal:  Physiol Rep       Date:  2022-05

5.  The activation of Na+-dependent efflux of Ca2+ from liver mitochondria by glucagon and beta-adrenergic agonists.

Authors:  T P Goldstone; R J Duddridge; M Crompton
Journal:  Biochem J       Date:  1983-02-15       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.